Skip to main content
NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%

About BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Therapeutics (BBOT) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for BBOT on iGotFomo.

BBOT Key Statistics

BBOT key financial statistics
Current Price$8.81Market Cap$713 million
Daily Change+1.03%Volume256K
52-Week High$14.8752-Week Low$7.60
P/E Ratio (TTM)156.42Forward P/E-4.16
SectorHealthcareIndustryBiotechnology

Frequently Asked Questions About BBOT

What is BridgeBio Oncology Therapeutics (BBOT)?
BridgeBio Oncology Therapeutics (BBOT) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
What is the current BBOT stock price?
As of the latest trading session, BBOT trades at $8.81 per share, with a daily change of +1.03%.
What is BBOT's market capitalization?
BridgeBio Oncology Therapeutics has a market capitalization of $713 million, making it a small-cap stock.
What sector does BBOT belong to?
BridgeBio Oncology Therapeutics operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.